Investing Profile

Paul Berns

InvestorVC

Managing Director at ARCH Venture Partners

Your Intro Paths to Paul Berns

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Paul Berns on

Current Investing Position

Investment Range

$50K - $150.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

$635.8M

Paul Berns is on these Sector & Stage Rankings

Paul Berns's Investments On Record (12)

Company	StageDateRound Size	Total Raised
Salma Health	Series AFeb 2026$80M	$80M
Co-investors: Alaa Halawa (Vir Biotechnology, Inc.)
Elephas	Series UnknownNov 2025$40M Series CJan 2024$55M Series BSep 2022$42M	$140M
Kardigan	Series BOct 2025$250M Series AJan 2025$300M	$550M
Ollin Biosciences	Series ASep 2025$100M	$430M
Co-investors: Alaa Halawa (Vir Biotechnology, Inc.)
Tenvie Therapeutics	Series AJan 2025$200M	$200M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Alaa Halawa (Vir Biotechnology, Inc.), Kristina Burow (ARCH Venture Partners)
Metsera	Series BNov 2024$220M Series AApr 2024$290M	$510M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Sherry Chao (GV (Google Ventures)), Kristina Burow (ARCH Venture Partners), Nimish Shah (Venrock)
Matter Neuroscience	SeedFeb 2024$26M	$26M
Co-investors: Amir Nashat (Polaris Venture Partners)
Areteia Therapeutics	Series AFeb 2024$75M Series AJul 2022$350M	$430M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Adam Koppel (Bain Capital Life Sciences)